hsa-mir-1913: Hsa-mir-1913 is a microRNA that has been identified in various studies [PMC6029031]. It is expressed in infected cells compared to uninfected cells [PMC6029031]. It has been detected in experiments and found to be expressed in tumor tissues [PMC7398623, PMC9340001]. However, its role in prostate has not been studied yet [PMC8100013]. The genomic interval for hsa-mir-1913 is not present in mice, and the mature hsa-miR-769 is not conserved in mice, suggesting that these miRNAs do not have a potential cleavage role [PMC3333847]. Hsa-mir-1913 has been found to interact with other miRNAs and lncRNAs, such as hsa-miR-2355 and TP53TG1 [PMC9307901]. Mutations have been identified within the sequence target for hsa-mir-1913, which can affect its interactions with other molecules [PMC3766605]. In silico analyses have shown that these mutations introduce mismatches that abolish the interactions of hsa-mir-1913 with other miRNAs [PMC3766605]. The expression of hsa-mir-1913 has also been associated with poor overall survival in certain cancers such as CESC [PMC7333649]. However, further studies are needed to fully understand the functions and roles of hsa-mir-1913 [PMC8321750].